Christophe Weber is president, chief executive officer (CEO) and representative director of Takeda. He joined the company in April 2014 as chief operating officer, was named president and representative director in June 2014, and was subsequently appointed CEO in April 2015.

22 hours ago · CEO Christophe Weber to retire from Takeda in June 2026 after 12 years. Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process.

1 day ago · CEO Christophe Weber to retire from Takeda in June 2026 after 12 years Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process “The Board of ...

18 hours ago · Takeda announced that its board of directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda ...

21 hours ago · Takeda Pharmaceutical Company Limited / Key word(s): Personnel Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026 30-Jan-2025 / 09:31 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.

19 hours ago · Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Taked ...

22 hours ago · CEO Christophe Weber to retire from Takeda in June 2026 after 12 yearsJulie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process Takeda(TOKYO:4502/NYSE:TAK) announced today that itsBoard of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, …

17 hours ago · Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook. Julie Kim, president of the company's U.S. unit, was named to succeed Weber in June 2026. Weber, one of ...

1 day ago · Takeda Pharmaceutical Co.’s board has selected Julie Kim, the head of the company’s US unit, to replace Christophe Weber as the drugmaker’s new chief executive officer. Kim, who has been ...

22 hours ago · Takeda (TOKYO:4502/NYSE:TAK) has announced that Julie Kim, current president of Takeda's U.S. Business Unit, will succeed Christophe Weber as CEO when he retires in June 2026. The decision was made unanimously by the Board of Directors after a multi-year succession process evaluating both internal and external candidates.Weber, who joined …